About Index Trending news
Analyze
Top 50 Pricing
Tarveda Therapeutics

Tarveda Therapeutics

Work at Tarveda Therapeutics? Add yourself to this profile

Tarveda Therapeutics

Blend discovers and develops integrative nanomedicines to target distinctdisease pathways safely and efficiently.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding
Venture capital (Series D)
$30,000,000
Venture capital (Series C)
$38,000,000
Employees

Team size

10+
Locations
HQ
Headquarters
$30,000,000 Venture capital (Series D)
FinSMEs , Xconomy

Tarveda Therapeutics Raises $30M in Series D Financing

Funding Health
Xconomy

With $163M Deal, Tarveda Revives Synta Pharma's Cancer Drug Work

Health Strategy
Xconomy

Tarveda Formally Spins Out Placon to Advance Platinum Cancer Drugs

$38,000,000 Venture capital (Series C)
Xconomy , FinSMEs

Blend Rebrands as Tarveda, Raises $38M, and Spins Out Cancer Drug